Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
NPJ Vaccines|July 11, 2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variantsKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Open Forum Infectious Diseases|March 4, 2015
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical TrialMark J Mulligan, David I Bernstein, Sharon Frey, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Research Square|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) TrialAngela Branche, Nadine Rouphael, David Diemert, et al.
Pageof 21